Abstract
In gastric cancer, the urokinase‐type plasminogen activator (uPA) system plays important roles in invasion and metastasis, processes which entail proteolysis and adhesion. Both the urokinasetype plasminogen activator receptor (uPAR) and the plasminogen activator inhibitor‐1 (PAI‐1) are thought to be important factors in this system. To clarify the relationship between these two factors and gastric cancer invasiveness, we evaluated the expression of uPAR and PAI‐1 in 91 cases of gastric cancer by immunohistochemistry and in situ hybridization. Urokinase‐type plasminogen activator receptor‐mRNA, PAI‐1‐mRNA, uPAR and PAI‐1 protein were diffusely distributed in the cytoplasm of the cancer cells and concentrated at invasive foci. Urokinase‐type plasminogen activator receptor protein expression correlated with lymphatic, venous invasion (P<.01) and lymph node metastasis (PPPPP<0.05). This suggests that the proteolytic activity of uPAR and the cellular motility of PAI‐1 in gastric cancer cells may determine penetration of lymphatic and blood vessels, whereby lymph node metastasis may be promoted and that the promotion of cellular motility by PAI‐1 may influence the depth of cancer invasion.

This publication has 34 references indexed in Scilit: